Essex Financial Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$562K Sell
2,653
-69
-3% -$13.5K 0.03% 449
2026
Q1
$533K Buy
2,722
+252
+10% +$49K 0.03% 442
2025
Q4
$429K Sell
2,470
-441
-15% -$80.3K 0.02% 484
2025
Q3
$555K Buy
2,911
+279
+11% +$49.5K 0.03% 396
2025
Q2
$473K Buy
2,632
+186
+8% +$32.3K 0.03% 420
2025
Q1
$414K Buy
2,446
+159
+7% +$26.1K 0.03% 422
2024
Q4
$345K Buy
2,287
+131
+6% +$20.4K 0.02% 455
2024
Q3
$340K Buy
2,156
+37
+2% +$5.53K 0.02% 457
2024
Q2
$318K Buy
+2,119
New +$290K 0.02% 459
2022
Q1
Sell
-1,340
Closed -$232K 511
2021
Q4
$232K Buy
+1,340
New +$204K 0.02% 434

Other funds holding DGX

Essex Financial Services's DGX Position: Q2 2026 in Review

Essex Financial Services reduced its Quest Diagnostics (DGX) stake by 2.5% in Q2 2026, selling an estimated $13.5K and leaving 2,653 shares worth $562K. The position accounts for 0.03% of the portfolio, ranked #449.

Essex Financial Services first reported a position in DGX in Q4 2021 and has held it in 10 quarters since. 802 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Essex Financial Services held 2,653 shares of Quest Diagnostics worth $562K as of Q2 2026.
  • Essex Financial Services sold 69 Quest Diagnostics shares in Q2 2026, an estimated $13.5K.
  • Quest Diagnostics made up 0.03% of Essex Financial Services's portfolio in Q2 2026, its #449 holding.
  • Essex Financial Services first reported a position in Quest Diagnostics in Q4 2021 and has held it in 10 quarters since.
  • 802 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Essex Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.